The role of tocilizumab therapy in critically ill patients with severe acute respiratory syndrome coronavirus 2
{{output}}
Context: Tocilizumab (TCZ), an interleukin-6 (IL-6) receptor antagonist, has been approved for use in rheumatoid arthritis and cytokine storm syndrome (CSS) associated with chimeric antigen receptor T cells treatment. Although TC... ...
